Description of the 3 Tranquillo Phase 3 clinical program study designs to assess ritlecitinib treatment in adults and adolescents with nonsegmental vitiligo. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 25];9(6):s714. Available from: https://skin.dermsquared.com/skin/article/view/3860